NFAT3 Antibody [H15F22]

Catalog No.: F4697

Print

Biological Description

Specificity NFAT3 Antibody [H15F22] detects endogenous levels of total NFAT3 protein.
Background NFAT3 (NFATc4), a nuclear factor of activated T-cells (NFAT) family transcription factor predominantly expressed in T cells, B cells, and cardiac myocytes, contains an intrinsically disordered N-terminal regulatory domain with serine-rich regions (SRR) and SP-repeat motifs that serve as calcineurin docking sites, a central Rel homology region (RHR) immunoglobulin-like fold with a DNA-binding domain recognizing GGAAA consensus sequences and a nuclear localization signal (NLS), and a C-terminal transactivation domain (TAD) that recruits CBP/p300 coactivators. Upon T cell receptor (TCR) or GPCR stimulation, increased cytosolic Ca2+ activates calmodulin-bound calcineurin, which dephosphorylates 14 conserved serine residues in the SRR/SP regions, exposing the NLS and enabling nuclear translocation of NFAT3. In the nucleus, NFAT3 homodimerizes or cooperates with partners like AP-1 (c-Fos/c-Jun), GATA3, or MEF2 to transactivate cytokine genes (IL-2, IL-4, TNF-α) and FasL at composite NFAT:AP-1 sites, while in cardiomyocytes, it drives pathological hypertrophy by inducing BNP and MHCα gene expression. Nuclear export and cytoplasmic sequestration are restored by rephosphorylation through GSK3β, CK1, or PKA. Uniquely, NFAT3 represses cell cycle progression and promotes apoptosis in neurons via Trim17 induction, in contrast to the pro-death role of NFAT4; deficiency of NFAT3 impairs Th2 differentiation and IgE responses. Dysregulated nuclear hyperactivation of NFAT3 contributes to rheumatoid arthritis synovial inflammation, cardiac hypertrophy and failure under pressure overload, and B cell lymphomas through constitutive IL-2 signaling.

Usage Information

Application WB Dilution
WB
1:1000
Reactivity Human, Mouse, Rat
Source Rabbit Monoclonal Antibody MW 120-140 kDa
Storage Buffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Storage
(from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

References

  • https://pubmed.ncbi.nlm.nih.gov/9143705/
  • https://pubmed.ncbi.nlm.nih.gov/27100893/

Application Data

WB

Validated by Selleck

  • F4697-wb
    Lane 1: A204, Lane 2: A10, Lane 3: Hela